Skip to content
Study Examines Genetics Impact on Statin Disposition and Response episode artwork

Jan 14, 2016 12 min

Study Examines Genetics Impact on Statin Disposition and Response

from Transformational Pediatrics Hosted by Children’s Mercy Kansas City

Based on guidelines from the American Academy of Pediatrics (AAP), approximately 0.8 percent of adolescents 12 to 17 years old with dyslipidemia may qualify for pharmacological treatment. That translates into approximately 200,000 adolescents who could be eligible for statin therapy. With the increasing prevalence of overweight children, the incidence of clinically diagnosed coronary artery disease in young to middle-aged adults is expected to increase by 5 to 16 percent over the next two decades. Jon Wagner, DO, is here to discuss how he is leading a research study looking at the liver specific protein transporter, OATP1B1, which is the major transporter of statins from the blood to the liver to better understand how children’s bodies distribute statins in the body.

Episode details come from the podcast's RSS feed.

Embed this episode

Ready to play

Study Examines Genetics Impact on Statin Disposition and Response

0:00 12:42

No transcript yet.

Requests help us decide what to transcribe next.

Frequently asked questions

How long is this episode of Transformational Pediatrics?

This episode is 12 minutes long.

When was this Transformational Pediatrics episode published?

This episode was published on January 14, 2016.

Can I download this Transformational Pediatrics episode?

Yes. Use the download control on the episode player to save the publisher-provided media file.